How is the Brainstorm Cell Therapeutics, Inc. today?

The Brainstorm Cell Therapeutics, Inc. today is trading in the down by -4.84% at 1.18.

What is Brainstorm Cell Therapeutics, Inc. Stock Price?

Brainstorm Cell Therapeutics, Inc. Stock Price rose 107.02% and outperformed its sector by 95.69% in the past year.

What is Brainstorm Cell Therapeutics, Inc. Mutual Fund Holding?

Brainstorm Cell Therapeutics, Inc. Mutual Fund Holding decreased by 0.52% in the last quarter to 3.75.

What is Brainstorm Cell Therapeutics, Inc. Promoter Share Holding?

Brainstorm Cell Therapeutics, Inc. Promoter Share Holding stayed the same in the most recent quarter at 2.71%.

What is Brainstorm Cell Therapeutics, Inc. Institutional Holding?

Brainstorm Cell Therapeutics, Inc. Institutional Holding decreased by 0.16% in the last quarter to 16.68.

Brainstorm Cell Therapeutics, Inc. XNAS: BCLI

Brainstorm Cell Therapeutics, Inc. Live Share Price Today, Share Analysis and Chart

Name: Brainstorm Cell Therapeutics, Inc.: Is Infosys Ltd. worth buying?
Item: Brainstorm Cell Therapeutics, Inc.
Rating: 1.20050
Author: Trendlyne DVM scores

about

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progr...

1.18 -0.06 (-4.84%)

68.19% Fall from 52W High

1.1M XNAS Volume

High vol. this week

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Neutral

48.0 / 100

No estimates available

Brainstorm Cell Therapeuti... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Brainstorm Cell Therapeutics, Inc. FAQ

How is Brainstorm Cell Therapeutics, Inc. today?

Brainstorm Cell Therapeutics, Inc. today is trading in the red, and is down by -4.84% at 1.18.

How has Brainstorm Cell Therapeutics, Inc. performed historically?

Brainstorm Cell Therapeutics, Inc. is currently trading down -4.84% on an intraday basis. In the past week the stock fell -2.48%. stock has been down -34.44% in the past quarter and rose 107.02% in the past year. You can view this in the overview section.